Efficacy and Safety of Low-Dose Upadacitinib Combined With Ustekinumab in the Treatment of Refractory Crohn's Disease

Clinical trial NCT07697547 · COMPLETED

Trial details

NCT number: NCT07697547
Sponsor: Shanghai 10th People's Hospital
Status: COMPLETED
Study type: OBSERVATIONAL

Inflammatory Bowel Disease (IBD)Crohn's Disease

Start date: 2023-07-01
Primary completion: 2025-12-31
Enrollment: 84

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.